285 related articles for article (PubMed ID: 14645659)
21. N-terminal domains in mouse and human 5-hydroxytryptamine3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine.
Zhang R; White NA; Soti FS; Kem WR; Machu TK
J Pharmacol Exp Ther; 2006 Jun; 317(3):1276-84. PubMed ID: 16551836
[TBL] [Abstract][Full Text] [Related]
22. Importance of phenylalanine 107 in agonist recognition by the 5-hydroxytryptamine(3A) receptor.
Steward LJ; Boess FG; Steele JA; Liu D; Wong N; Martin IL
Mol Pharmacol; 2000 Jun; 57(6):1249-55. PubMed ID: 10825397
[TBL] [Abstract][Full Text] [Related]
23. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.
de la Fuente T; Martín-Fontecha M; Sallander J; Benhamú B; Campillo M; Medina RA; Pellissier LP; Claeysen S; Dumuis A; Pardo L; López-Rodríguez ML
J Med Chem; 2010 Feb; 53(3):1357-69. PubMed ID: 20078106
[TBL] [Abstract][Full Text] [Related]
24. The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
Cerutis DR; Hass NA; Iversen LJ; Bylund DB
Mol Pharmacol; 1994 Jan; 45(1):20-8. PubMed ID: 8302276
[TBL] [Abstract][Full Text] [Related]
25. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
Purohit A; Herrick-Davis K; Teitler M
Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
[TBL] [Abstract][Full Text] [Related]
26. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
Lan H; Durand CJ; Teeter MM; Neve KA
Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
[TBL] [Abstract][Full Text] [Related]
27. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
28. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.
Oksenberg D; Marsters SA; O'Dowd BF; Jin H; Havlik S; Peroutka SJ; Ashkenazi A
Nature; 1992 Nov; 360(6400):161-3. PubMed ID: 1436092
[TBL] [Abstract][Full Text] [Related]
29. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
Xie J; Dernovici S; Ribeiro P
J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
[TBL] [Abstract][Full Text] [Related]
30. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
Wesołowska A
Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
[TBL] [Abstract][Full Text] [Related]
31. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
[TBL] [Abstract][Full Text] [Related]
32. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.
Schechter LE; Lin Q; Smith DL; Zhang G; Shan Q; Platt B; Brandt MR; Dawson LA; Cole D; Bernotas R; Robichaud A; Rosenzweig-Lipson S; Beyer CE
Neuropsychopharmacology; 2008 May; 33(6):1323-35. PubMed ID: 17625499
[TBL] [Abstract][Full Text] [Related]
33. A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists.
López-Rodríguez ML; Benhamú B; de la Fuente T; Sanz A; Pardo L; Campillo M
J Med Chem; 2005 Jun; 48(13):4216-9. PubMed ID: 15974573
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies.
Ray AM; Kelsell RE; Houp JA; Kelly FM; Medhurst AD; Cox HM; Calver AR
Eur J Pharmacol; 2009 Feb; 604(1-3):1-11. PubMed ID: 19100256
[TBL] [Abstract][Full Text] [Related]
35. Position 5.46 of the serotonin 5-HT2A receptor contributes to a species-dependent variation for the 5-HT2C agonist (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: impact on selectivity and toxicological evaluation.
Miller KJ; Wu GY; Varnes JG; Levesque P; Li J; Li D; Robl JA; Rossi KA; Wacker DA
Mol Pharmacol; 2009 Dec; 76(6):1211-9. PubMed ID: 19767451
[TBL] [Abstract][Full Text] [Related]
36. [Serotonin receptors (results of the pharmacological study)].
Valeeva LA; Sergeev PV; Shimanovskiĭ NL
Eksp Klin Farmakol; 1997; 60(6):57-61. PubMed ID: 9460603
[TBL] [Abstract][Full Text] [Related]
37. Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor.
Gudermann T; Levy FO; Birnbaumer M; Birnbaumer L; Kaumann AJ
Mol Pharmacol; 1993 Mar; 43(3):412-8. PubMed ID: 8450834
[TBL] [Abstract][Full Text] [Related]
38. Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog.
Bonaventure P; Nepomuceno D; Miller K; Chen J; Kuei C; Kamme F; Tran DT; Lovenberg TW; Liu C
Eur J Pharmacol; 2005 Apr; 513(3):181-92. PubMed ID: 15862800
[TBL] [Abstract][Full Text] [Related]
39. WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.
Dunlop J; Sabb AL; Mazandarani H; Zhang J; Kalgaonker S; Shukhina E; Sukoff S; Vogel RL; Stack G; Schechter L; Harrison BL; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2005 May; 313(2):862-9. PubMed ID: 15705738
[TBL] [Abstract][Full Text] [Related]
40. The mouse brain adenosine A1 receptor: functional expression and pharmacology.
Wittendorp MC; von Frijtag Drabbe Künzel J; Ijzerman AP; Boddeke HW; Biber K
Eur J Pharmacol; 2004 Mar; 487(1-3):73-9. PubMed ID: 15033378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
